✦ LIBER ✦

299 Development of Novel Combination Therapy with Dalotuzumab and GSI for the Treatment of Cetuximab Refractory Colorectal Cancer

✍ Scribed by Naumov, G.; Howard, S.; Seeley, A.; Ware, C.; Reilly, J.; Cheng, J.; Sathyanarayanan, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combining Targeted Therapies to Enhance

✍ Cathy Eng 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Combination of cetuximab with cisplatin

✍ D.D. Meira; V.H. Almeida; J.S. Mororó; I. Nóbrega; D.V.S. Batista; L.H. Bardella 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

1095 Pharmacogenomic analysis of the tri

✍ E. Bandres; J. Rodriguez; A. Hernandez; N. Bitarte; N. Ramirez; J.A. Diaz-Gonzal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PCN17 THE COST-EFFECTIVENESS OF CETUXIMA

✍ D Tilden; D Thurley; J White; M Aristides 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Novel therapies for the treatment of pro

✍ Michael J. Morris; Howard I. Scher 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Therapeutic effect of the treatment for

✍ Tu, Zhenzhen; Ma, Yuxiang; Akers, Walter; Achilefu, Samuel; Gu, Yueqing 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 832 KB